These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6087783

  • 41. Hormone receptors in dystrophic and neoplastic vulvar disease. Preliminary considerations.
    Becagli L, Scrimin F, De Salvia D, Gambato M, Resta P, Ambrosini A.
    Clin Exp Obstet Gynecol; 1983; 10(2-3):145-9. PubMed ID: 6313258
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Tamoxifen therapy in premenopausal women with metastatic breast cancer.
    Planting AS, Alexieva-Figusch J, Blonk-vdWijst J, van Putten WL.
    Cancer Treat Rep; 1985 Apr; 69(4):363-8. PubMed ID: 3995508
    [Abstract] [Full Text] [Related]

  • 44. [Steroid hormone receptors in breast cancer].
    Nomura Y.
    Rinsho Byori; 1990 Jan; 38(1):26-30. PubMed ID: 2308219
    [Abstract] [Full Text] [Related]

  • 45. Hormone receptors in breast cancer and response to chemotherapy.
    Kaufmann M, Klinga K, Runnebaum B, Kubli F.
    N Engl J Med; 1979 May 03; 300(18):1052. PubMed ID: 219332
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Hormonal receptors in malignant breast pathology].
    Gomez F, Schmid M, Lemarchand-Beraud T.
    Minerva Ginecol; 1982 Nov 03; 34(11):951-8. PubMed ID: 6296731
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Steroid hormone receptors in breast carcinoma].
    Klinga K, Kaufmann M, Runnebaum B, Kubli F.
    Dtsch Med Wochenschr; 1982 Feb 26; 107(8):313-5. PubMed ID: 6277591
    [No Abstract] [Full Text] [Related]

  • 52. [Tamoxifen-induced progesterone receptors in breast tumors].
    Tsyrlina EV, Semiglazov VF, Nurgaziev KSh, Ivanova OA.
    Vopr Onkol; 1991 Feb 26; 37(9-10):916-21. PubMed ID: 1842650
    [Abstract] [Full Text] [Related]

  • 53. Tamoxifen in the treatment of male breast carcinoma.
    Ribeiro GG.
    Clin Radiol; 1983 Nov 26; 34(6):625-8. PubMed ID: 6673881
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. In vitro model systems for the study of hormone-dependent human breast cancer.
    Lippman ME, Osborne CK, Knazek R, Young N.
    N Engl J Med; 1977 Jan 20; 296(3):154-9. PubMed ID: 187935
    [No Abstract] [Full Text] [Related]

  • 58. The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast.
    Williams G, Howell A, Jones M.
    Br J Cancer; 1988 Nov 20; 58(5):631-4. PubMed ID: 3219275
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Current status of estrogen and progesterone receptors in breast cancer.
    McGuire WL, Horwitz KB, Pearson OH, Segaloff A.
    Cancer; 1977 Jun 20; 39(6 Suppl):2934-47. PubMed ID: 326386
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.